Haematological disease conditions
In this chapter you will learn about various Haematological disease conditions
Sickle cell disease: leg ulcers, kidney and eye complications
Chronic leg ulcers, kidney disease and eye disease are long-term complications of sickle cell disease (SCD); up to 20% of patients develop renal insufficiency and retinopathy tends to progress through adulthood. This article gives the national guideline features, investigations and management of leg ulcers, the kidney manifestations of SCD and the eye complications that need urgent referral.
Sickle cell disease: preventing infection, folic acid, nutrition and growth
Health maintenance in sickle cell disease (SCD) prevents severe infection and supports growth: penicillin V prophylaxis for children under 6 years, pneumococcal and other vaccines, folic acid 5 mg daily for life, a balanced diet with plenty of water, and regular growth monitoring. This article gives the national guideline doses and schedules.
Sickle cell disease: hydroxyurea therapy
Hydroxyurea reduces complications of sickle cell disease (SCD) in infants, children and adults by raising haemoglobin F and steady-state haemoglobin and lowering white cells and platelets; the national guideline recommends it for everyone with SCD from 9 months of age, continued for life. This article gives the baseline tests, starting doses (adults 15 mg/kg/day, children 20 mg/kg/day), monitoring schedule, dose escalation to a maximum of 30 mg/kg, toxicity rules, side effects and use in pregnancy.
Sickle cell disease: education, psychosocial support, transition, travel and support groups
Living well with sickle cell disease (SCD) needs regular education, psychosocial support, a planned transfer from paediatric to adult care, safe travel and peer support. This article gives the national guideline points for counselling patients and families at every visit, preparing adolescents for adult care from 14–15 years, advice for travel, and how to help patients organise a support group.
Sickle cell disease: newborn screening and early infant diagnosis
Early infant diagnosis (EID) screens newborns and infants for sickle cell disease (SCD) at birth or at the 6-, 10- and 14-week immunisation visits, so that life-saving care starts before symptoms; in Tanzania up to 90% of children with undiagnosed SCD may die before 5 years. This article gives the national step-by-step workflow within RCH services: who to screen, consent, sample collection, point-of-care tests, interpreting HbAA/HbAS/HbSS results, inconclusive results, and counselling and referral.
